Next generation sequencing for personalized therapy: About a class III BRAF N581K mutation associated to NRAS Q61L mutation in malignant melanoma: Case report.
BRAF
Melanoma
NRAS
Non V600 mutant
Treatment NGS
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
06
12
2022
revised:
13
06
2023
accepted:
17
07
2023
medline:
3
8
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
epublish
Résumé
In metastatic stage, therapeutic approach for malignant melanoma is particularly based on performance status, metastatic sites, and
Identifiants
pubmed: 37533985
doi: 10.1016/j.heliyon.2023.e18420
pii: S2405-8440(23)05628-1
pmc: PMC10391937
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e18420Informations de copyright
© 2023 The Authors. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Pers Med. 2021 Apr 29;11(5):
pubmed: 33947144
Case Rep Oncol. 2016 Sep 22;9(3):543-546
pubmed: 27790118
Br J Dermatol. 2017 Sep;177(3):860-861
pubmed: 27925152
Cancer. 2012 Aug 15;118(16):4014-23
pubmed: 22180178
Clin Cancer Res. 2018 Dec 15;24(24):6483-6494
pubmed: 29903896
Crit Rev Oncol Hematol. 2020 Dec;156:103119
pubmed: 33053439
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Lancet Oncol. 2017 Apr;18(4):435-445
pubmed: 28284557
J Clin Oncol. 2019 Nov 20;37(33):3142-3151
pubmed: 31580757
Cell. 2010 Jan 22;140(2):209-21
pubmed: 20141835
Melanoma Res. 2020 Feb;30(1):62-70
pubmed: 31274706
Int J Mol Sci. 2021 Apr 06;22(7):
pubmed: 33917428
Cancers (Basel). 2023 Jan 24;15(3):
pubmed: 36765665
Pharmacol Res. 2016 May;107:111-116
pubmed: 26987942
Mol Cancer Ther. 2015 Aug;14(8):1962-71
pubmed: 26063764
Oncologist. 2021 Sep;26(9):731-e1498
pubmed: 33861486
Oncologist. 2019 May;24(5):657-663
pubmed: 30683711
Cancer Med. 2020 Jul;9(14):4881-4896
pubmed: 32476297
Clin Cancer Res. 2018 Dec 15;24(24):6107-6109
pubmed: 30042206
Hepatobiliary Pancreat Dis Int. 2021 Oct;20(5):506-507
pubmed: 33334695
Target Oncol. 2019 Dec;14(6):729-742
pubmed: 31754963
Oncogene. 2018 Jun;37(24):3183-3199
pubmed: 29540830
Anticancer Res. 2020 Jun;40(6):3013-3030
pubmed: 32487595
Cancer Discov. 2012 Sep;2(9):791-7
pubmed: 22798288
Cancers (Basel). 2020 Feb 19;12(2):
pubmed: 32092958
Nature. 2017 Aug 10;548(7666):234-238
pubmed: 28783719